Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Bicara Therapeutics Inc. | 23,746 | reported | 09 Jun 2025 | tx 2+47,492 |
| Septerna, Inc. | 16,623 | reported | 17 Jun 2025 | tx 1+16,623 |
| Tyra Biosciences, Inc. | 13,160 | reported | 28 May 2026 | tx 5+82,960 |
| Janux Therapeutics, Inc. | 11,667 | reported | 11 Jun 2025 | tx 7+81,267 |
| DICE Therapeutics, Inc. | 0 | reported | 09 Aug 2023 | tx 2+21,250−21,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | Tyra Biosciences, Inc. | 13,160 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | Septerna, Inc. | 16,623 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 3,750 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 11,667 | 0.00 USD | deriv |
| 09 Jun 2025 | GRANT_AWARD | Bicara Therapeutics Inc. | 23,746 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | Tyra Biosciences, Inc. | 22,200 | 0.00 USD | deriv |
| 12 Sept 2024 | GRANT_AWARD | Bicara Therapeutics Inc. | 23,746 | 0.00 USD | deriv |
| 26 Jun 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 2,500 | 0.00 USD | |
| 26 Jun 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 8,350 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Tyra Biosciences, Inc. | 18,600 | 0.00 USD | deriv |
| 09 Aug 2023 | OTHER | DICE Therapeutics, Inc. | 21,250 | — | deriv |
| 14 Jun 2023 | GRANT_AWARD | Janux Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 31 May 2023 | GRANT_AWARD | Tyra Biosciences, Inc. | 14,500 | 0.00 USD | deriv |
| 14 Jun 2022 | GRANT_AWARD | Janux Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 13 Jun 2022 | GRANT_AWARD | Tyra Biosciences, Inc. | 14,500 | 0.00 USD | deriv |
| 07 Jun 2022 | GRANT_AWARD | DICE Therapeutics, Inc. | 21,250 | 0.00 USD | deriv |
| 10 Jun 2021 | GRANT_AWARD | Janux Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |